Tomomi Ikemoto
Takeda Pharmaceutical Company
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Tomomi Ikemoto.
Journal of Organic Chemistry | 2010
Naohiro Fukuda; Tomomi Ikemoto
A new combination system, the oxidation of sulfides using aqueous NaOCl in the presence of a catalytic amount of imide under two-phase conditions, has been developed. The combination effectively converts various sulfides to the corresponding sulfoxides and sulfones. It was deduced that the imide could react with NaOCl to produce N-chloroimide, which would play roles of both the active oxidizing reagent and phase transfer catalyst.
Tetrahedron-asymmetry | 2003
Tatsuya Ito; Tomomi Ikemoto; Toru Yamano; Yukio Mizuno; Kiminori Tomimatsu
Abstract A practical method for the preparation of ( R )-(+)-6-(1,4-dimethoxy-3-methyl-2-naphthyl)-6-(4-hydroxyphenyl)hexanoic acid ( R )- 2 , a key intermediate for a therapeutic drug for neurodegenerative diseases, has been developed. rac -Methyl 6-(1,4-dimethoxy-3-methyl-2-naphthyl)-6-(4-(propionyloxy)phenyl) hexanoate rac - 9b was synthesized from 2-methylnaphthoquinone in seven steps. An optically active ester ( R )- 9b was readily obtained from the corresponding racemic ester by lipase-catalyzed resolution, followed by sulfation or phosphorylation. Sulfation by a sulfur trioxide pyridine complex or phosphorylation by phosphoryl chloride enabled facile isolation of the optically active ester simply by extraction. Optically active acid ( R )- 2 was synthesized in excellent enantiomeric excess by hydrolysis of ( R )- 9b followed by recrystallization. The present synthesis of ( R )- 2 was accomplished in 10 steps without requiring chromatographic purification.
Tetrahedron | 2002
Tomomi Ikemoto; Tetsuji Kawamoto; Hiroki Wada; Toru Ishida; Tatsuya Ito; Yasushi Isogami; Yoshiko Miyano; Yukio Mizuno; Kiminori Tomimatsu; Kazumasa Hamamura; Muneo Takatani; Mitsuhiro Wakimasu
Abstract The 5-thia-1,8b-diazaacenaphthylenes ( 2 and its ester, 8 ) are new cyclazines, in which a paramagnetic ring is present in the peripheral 12π-electron ring system. Three convenient methods of preparing 8 have been developed. One involved thioglycolation of a new compound, 5-fluoroimidazo[1,2- a ]pyridine ( 6b ), followed by the Duff reaction gave 8 in 64% yield without chromatographic purification.
Tetrahedron | 2000
Tomomi Ikemoto; Tetsuji Kawamoto; Kiminori Tomimatsu; Muneo Takatani; Mitsuhiro Wakimasu
Abstract A convenient synthesis of the chronic renal disease agent, trifluoro-N-[4-(3-oxo-3,5-dihydro-4H-1,4,8b-triazaacenaphthylen-4-yl)butyl]methanesulfonamide (1a), for large scale has been developed via ethyl 5-(chloromethyl)imidazo[1,2-a]pyridine-3-carboxylate (3), which was given by the regioselective chlorination of ethyl 5-methylimidazo[1,2-a]pyridine-3-carboxylate (6) with N-chlorosuccinimide (NCS) using AcOEt as a solvent in 83% yield. The condensation of 3 and primary amines gave 4,5-dihydro-3H-1,4,8b-triazaacenaphthylen-3-one derivatives (1) in good yields. The present synthesis of 1a was accomplished in five steps from 2-amino-6-methylpyridine (4) without requiring a chromatographic method.
Tetrahedron | 2001
Tomomi Ikemoto; Atsuko Nishiguchi; Hiroyuki Mitsudera; Mitsuhiro Wakimasu; Kiminori Tomimatsu
Abstract A convenient and efficient synthesis of TAK-779 (1a), a nonpeptide CCR5 antagonist, has been achieved. The new methylation of tertiary amine (2) using trimethyl phosphite and N-chlorosuccinimide, followed by the addition of HCl led to ammonium chloride (1a) in 89% isolated yield without requiring a chromatographic method. By this preparation, ammonium methanesulfonate (1e) could be obtained in 75% isolated yield.
Tetrahedron Letters | 2000
Tetsuji Kawamoto; Kiminori Tomimatsu; Tomomi Ikemoto; Hidenori Abe; Kazumasa Hamamura; Muneo Takatani
Novel 5-thia-1-azacycl[3.3.2]azine derivatives 1 , 5-thia-1,8b-diazaacenaphthylenes, have successfully been prepared. An X-ray crystallographic analysis of 1c revealed that the 5-thia-1-azacycl[3.3.2]azine ring system adopts a planar structure as to the internal ring nitrogen atom. The 1 H NMR spectrum for unsubstituted ring system 1d implies contribution of a paramagnetic ring current in the peripheral 12π-electron ring system. Also, 3 H -1,4-diazacycl[3.3.2]azine derivatives, 4-benzyl-4,5-dihydro-3 H -1,4,8b-triazaacenaphthylen(e)-3-ones 2 and -3,5-diones 3 were synthesized with high efficiency via 3-(trichloroacetyl)imidazo[1,2- a ]pyridine derivatives as new useful synthetic intermediates.
Bioorganic & Medicinal Chemistry | 2015
Masato Yoshikawa; Haruhi Kamisaki; Jun Kunitomo; Hideyuki Oki; Hironori Kokubo; Akihiro Suzuki; Tomomi Ikemoto; Kosuke Nakashima; Naomi Kamiguchi; Akina Harada; Haruhide Kimura; Takahiko Taniguchi
Highly potent and brain-penetrant phosphodiesterase 10A (PDE10A) inhibitors based on the 2-oxindole scaffold were designed and synthesized. (2-Oxo-1,3-oxazolidin-3-yl)phenyl derivative 1 showed the high P-glycoprotein (P-gp) efflux (efflux ratio (ER)=6.2) despite the potent PDE10A inhibitory activity (IC50=0.94 nM). We performed an optimization study to improve both the P-gp efflux ratio and PDE10A inhibitory activity by utilizing structure-based drug design (SBDD) techniques based on the X-ray crystal structure with PDE10A. Finally, 1-(cyclopropylmethyl)-4-fluoro-5-[5-methoxy-4-oxo-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-1(4H)-yl]-3,3-dimethyl-1,3-dihydro-2H-indol-2-one (19e) was identified with improved P-gp efflux (ER=1.4) and an excellent PDE10A inhibitory activity (IC50=0.080 nM). Compound 19e also exhibited satisfactory brain penetration, and suppressed PCP-induced hyperlocomotion with a minimum effective dose of 0.3mg/kg by oral administration in mice.
Chemical & Pharmaceutical Bulletin | 1995
Tomomi Ikemoto; Akira Haze; Hiroyuki Hatano; Yoshifumi Kitamoto; Masato Ishida; Kiyoshi Nara
Tetrahedron Letters | 2004
Tomomi Ikemoto; Toshiaki Nagata; Mitsuhisa Yamano; Tatsuya Ito; Yukio Mizuno; Kiminori Tomimatsu
Heterocycles | 2001
Tomomi Ikemoto; Mitsuhiro Wakimasu